A polymorphism controlling ORMDL3 expression is associated with asthma that is poorly controlled by current medications
- 30 April 2008
- journal article
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 121 (4) , 860-863
- https://doi.org/10.1016/j.jaci.2008.01.015
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Genetic variants regulating ORMDL3 expression contribute to the risk of childhood asthmaNature, 2007
- Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controlsNature, 2007
- A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancerNature Genetics, 2007
- Arginine-16 2 adrenoceptor genotype predisposes to exacerbations in young asthmatics taking regular salmeterolThorax, 2006
- Loss-of-function variations within the filaggrin gene predispose for atopic dermatitis with allergic sensitizationsJournal of Allergy and Clinical Immunology, 2006
- Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitisNature Genetics, 2006
- Asthma genetics 2006: the long and winding road to gene discoveryGenes & Immunity, 2006
- A genome-wide search for linkage to asthma phenotypes in the genetics of asthma international network families: evidence for a major susceptibility locus on chromosome 2pEuropean Journal of Human Genetics, 2006
- Contribution of ADAM33 polymorphisms to the population risk of asthmaThorax, 2005
- Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomised, placebo-controlled cross-over trialPublished by Elsevier ,2004